Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip D Dunne

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Histopathology|September 28, 2021
Development of a semi-automated method for tumour budding assessment in colorectal cancer and comparison with manual methodsNatalie C Fisher, Maurice B Loughrey, Helen G Coleman, et al.
Histopathology|March 24, 2017
Response to Park et al. reply to 'Back to the future: routine morphological assessment of the tumour microenvironment is prognostic in stage II/III colon cancer in a large population-based study'Seán O Hynes, Helen G Coleman, Paul J Kelly, et al.
Human Molecular Genetics|June 4, 2011
DNMT1 deficiency triggers mismatch repair defects in human cells through depletion of repair protein levels in a process involving the DNA damage responseJayne E P Loughery, Philip D Dunne, Karla M O'Neill, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|August 13, 2019
Prognosis following surgical resection versus local excision of stage pT1 colorectal cancer: A population-based cohort studyRachael McBride, Blanaid M Hicks, Helen G Coleman, et al.
BMC Systems Biology|September 11, 2015
Connectivity mapping using a combined gene signature from multiple colorectal cancer datasets identified candidate drugs including existing chemotherapiesQing Wen, Paul O'Reilly, Philip D Dunne, et al.
Plos One|July 11, 2013
Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq DataDarragh G McArt, Philip D Dunne, Jaine K Blayney, et al.
Oncotarget|December 15, 2016
KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapiesQing Wen, Philip D Dunne, Paul G O'Reilly, et al.
Carcinogenesis|February 3, 2026
Smoking, alcohol and colon cancer survival is modified by immune biomarkers: a population-representative studyYasemin Adali, Maurice B Loughrey, Stephanie Craig, et al.
Briefings in Bioinformatics|June 4, 2016
Embracing an integromic approach to tissue biomarker research in cancer: Perspectives and lessons learnedGerald Li, Peter Bankhead, Philip D Dunne, et al.
British Journal of Pharmacology|March 7, 2017
Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2Declan McLaughlin, Youyou Zhao, Karla M O'Neill, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Histopathology|September 28, 2021
Development of a semi-automated method for tumour budding assessment in colorectal cancer and comparison with manual methodsNatalie C Fisher, Maurice B Loughrey, Helen G Coleman, et al.
Histopathology|March 24, 2017
Response to Park et al. reply to 'Back to the future: routine morphological assessment of the tumour microenvironment is prognostic in stage II/III colon cancer in a large population-based study'Seán O Hynes, Helen G Coleman, Paul J Kelly, et al.
Human Molecular Genetics|June 4, 2011
DNMT1 deficiency triggers mismatch repair defects in human cells through depletion of repair protein levels in a process involving the DNA damage responseJayne E P Loughery, Philip D Dunne, Karla M O'Neill, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|August 13, 2019
Prognosis following surgical resection versus local excision of stage pT1 colorectal cancer: A population-based cohort studyRachael McBride, Blanaid M Hicks, Helen G Coleman, et al.
BMC Systems Biology|September 11, 2015
Connectivity mapping using a combined gene signature from multiple colorectal cancer datasets identified candidate drugs including existing chemotherapiesQing Wen, Paul O'Reilly, Philip D Dunne, et al.
Plos One|July 11, 2013
Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq DataDarragh G McArt, Philip D Dunne, Jaine K Blayney, et al.
Oncotarget|December 15, 2016
KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapiesQing Wen, Philip D Dunne, Paul G O'Reilly, et al.
Carcinogenesis|February 3, 2026
Smoking, alcohol and colon cancer survival is modified by immune biomarkers: a population-representative studyYasemin Adali, Maurice B Loughrey, Stephanie Craig, et al.
Briefings in Bioinformatics|June 4, 2016
Embracing an integromic approach to tissue biomarker research in cancer: Perspectives and lessons learnedGerald Li, Peter Bankhead, Philip D Dunne, et al.
British Journal of Pharmacology|March 7, 2017
Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2Declan McLaughlin, Youyou Zhao, Karla M O'Neill, et al.
Pageof 9